Dacomitinib Anhydrous vs Gefitinib

## Dacomitinib Anhydrous vs Gefitinib: Overview

This comparison examines the pharmacological differences between **Dacomitinib Anhydrous** and **Gefitinib**.

## Mechanism of Action

**Gefitinib**: Selective reversible inhibitor of EGFR tyrosine kinase.

## Pharmacokinetics

**Half-life**: Dacomitinib Anhydrous — N/A; Gefitinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Dacomitinib Anhydrous — N/A; Gefitinib — C22H24ClFN4O3.

**Molecular Weight**: Dacomitinib Anhydrous — N/A; Gefitinib — 446.9000 g/mol.

**Type**: Dacomitinib Anhydrous — Small molecule; Gefitinib — Small molecule.